Literature DB >> 2830481

Phosphorylation of deoxyguanosine in intact and fractured mitochondria.

L F Watkins1, R A Lewis.   

Abstract

The phosphorylation of deoxyguanosine was measured in fractured and intact mitochondria and an apparent Km of 16 microM for deoxyguanosine was calculated using fractured mitochondria. The effects of various deoxynucleotides on the phosphorylating activity in fractured organelles was tested at both a high and low ratio of NXP/ATP and at two pH values, 7.0 and 5.5. Exogenous dGTP, dGDP or dITP were inhibitory under all conditions tested. With a NXP/ATP ratio of 0.08 at pH 7.0, TTP, TDP, dADP, ADP, UTP and UDP were stimulatory, but at pH 5.5 only TTP elicited that response. When the NXP/ATP ratio was 10 at pH 5.5, TTP and UTP increased the activity more than 10-fold, whereas, at pH 7.0 TTP, TDP, dADP, ADP, UTP, UDP caused stimulation, but to a much lesser extent. When exogenous Mg2+, Mn2+ or Ca2+ were added to intact mitochondria, the rates of phosphorylation were lowered. In fractured mitochondria in the absence of exogenous ATP, little phosphorylation occurs, hence these metal ions caused little change. ATP-Mg, ATP-Mn and ATP-Ca, each at 0.05 mM caused a small inhibition with intact mitochondria, whereas, these compounds supported phosphorylation with fractured organelles. ATP-Mn (10 mM) or ATP-Ca (10 mM) stimulated phosphorylation in both intact and fractured mitochondria. Intact mitochondria synthesized dGMP, dGDP and dGTP when metal ion or ATP-Me concentrations were low (0.05 mM) or when Mg2+ concentration was high (10 mM). Additions of ATP-Ca, ATP-Mn, ATP-Mg, Mn2+ or Ca2+ at 10 mM cause the loss of dGDP and dGTP formation and, in most cases, an increase in the synthesis of dGMP.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2830481     DOI: 10.1007/BF00221924

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  11 in total

1.  Deoxyguanosine kinase. Distinct molecular forms in mitochondria and cytosol.

Authors:  W R Gower; M C Carr; D H Ives
Journal:  J Biol Chem       Date:  1979-04-10       Impact factor: 5.157

2.  Mitochondrial and herpesvirus-specific deoxypyrimidine kinases.

Authors:  W C Leung; D R Dubbs; D Trkula; S Kit
Journal:  J Virol       Date:  1975-09       Impact factor: 5.103

3.  The metabolism of deoxyguanosine in mitochondria: a characterization of the phosphorylation process which occurs in intact mitochondria.

Authors:  L F Watkins; R A Lewis
Journal:  Biochim Biophys Acta       Date:  1987-01-20

4.  A genetically distinct thymidine kinase in mammalian mitochondria. Exclusive labeling of mitochondrial deoxyribonucleic acid.

Authors:  A J Berk; D A Clayton
Journal:  J Biol Chem       Date:  1973-04-25       Impact factor: 5.157

5.  Coupling of adenosine triphosphate formation in mitochondria to the formation of nucleoside triphosphates. Involvement of nucleoside diphosphokinase.

Authors:  P L Pedersen
Journal:  J Biol Chem       Date:  1973-06-10       Impact factor: 5.157

6.  Metabolism of nucleosides by isolated mouse liver mitochondria.

Authors:  A S Tsiftsoglou; J G Georgatsos
Journal:  Biochim Biophys Acta       Date:  1972-03-24

7.  Regulation of the mitochondrial adenine nucleotide pool size.

Authors:  J R Aprille; J Austin
Journal:  Arch Biochem Biophys       Date:  1981-12       Impact factor: 4.013

8.  Properties of a nucleoside diphosphokinase from liver mitochondria and its relationship to the adenosine triphosphate-adenosine diphosphate exchange reaction.

Authors:  R P Glaze; C L Wadkins
Journal:  J Biol Chem       Date:  1967-05-10       Impact factor: 5.157

9.  Relationship between 5'-nucleotidase, adenosine deaminase, AMP deaminase, ATP-(Mg2+)-ase activities and dTMP kinase activity in rat liver mitochondria.

Authors:  J Greger; K Fabianowska
Journal:  Enzyme       Date:  1979

10.  Human deoxycytidine kinase. Purification and characterization of the cytoplasmic and mitochondrial isozymes derived from blast cells of acute myelocytic leukemia patients.

Authors:  Y C Cheng; B Domin; L S Lee
Journal:  Biochim Biophys Acta       Date:  1977-04-12
View more
  1 in total

1.  A proof-of-principle pharmacokinetic, pharmacodynamic, and clinical study with purine nucleoside phosphorylase inhibitor immucillin-H (BCX-1777, forodesine).

Authors:  Varsha Gandhi; John M Kilpatrick; William Plunkett; Mary Ayres; Leigh Harman; Min Du; Shanta Bantia; Jan Davisson; William G Wierda; Stefan Faderl; Hagop Kantarjian; Deborah Thomas
Journal:  Blood       Date:  2005-08-30       Impact factor: 22.113

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.